HEADER RNA BINDING PROTEIN 06-OCT-20 7D7U TITLE CRYSTAL STRUCTURE OF AGO2 MID DOMAIN IN COMPLEX WITH 8-BR-ADENOSIN-5'- TITLE 2 MONOPHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN ARGONAUTE-2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: MID DOMAIN; COMPND 5 SYNONYM: HAGO2,ARGONAUTE RISC CATALYTIC COMPONENT 2,EUKARYOTIC COMPND 6 TRANSLATION INITIATION FACTOR 2C 2,EIF2C 2,PAZ PIWI DOMAIN PROTEIN, COMPND 7 PPD,PROTEIN SLICER; COMPND 8 EC: 3.1.26.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AGO2, EIF2C2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ARGONAUTE, MID DOMAIN, RIBONUCLEOPROTEIN, RNA-BINDING, RNA-MEDIATED KEYWDS 2 GENE SILENCING, TRANSLATION REGULATION, RNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.SUZUKI,Y.TAKAHASHI,J.SAITO,H.MIYAGI,F.SHINOHARA REVDAT 3 29-NOV-23 7D7U 1 REMARK REVDAT 2 03-FEB-21 7D7U 1 JRNL REVDAT 1 25-NOV-20 7D7U 0 JRNL AUTH F.SHINOHARA,T.OASHI,T.HARUMOTO,T.NISHIKAWA,Y.TAKAYAMA, JRNL AUTH 2 H.MIYAGI,Y.TAKAHASHI,T.NAKAJIMA,T.SAWADA,Y.KODA,A.MAKINO, JRNL AUTH 3 A.SATO,K.HAMAGUCHI,M.SUZUKI,J.YAMAMOTO,Y.TOMARI,J.I.SAITO JRNL TITL SIRNA POTENCY ENHANCEMENT VIA CHEMICAL MODIFICATIONS OF JRNL TITL 2 NUCLEOTIDE BASES AT THE 5'-END OF THE SIRNA GUIDE STRAND. JRNL REF RNA V. 27 163 2021 JRNL REFN ESSN 1469-9001 JRNL PMID 33177188 JRNL DOI 10.1261/RNA.073783.119 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0232 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 28480 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1495 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2128 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3119 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.02000 REMARK 3 B22 (A**2) : -1.83000 REMARK 3 B33 (A**2) : 0.77000 REMARK 3 B12 (A**2) : 0.19000 REMARK 3 B13 (A**2) : -2.07000 REMARK 3 B23 (A**2) : 0.65000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.202 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.177 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.216 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.917 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3254 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3099 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4410 ; 1.546 ; 1.652 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7218 ; 1.265 ; 1.574 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 398 ; 7.709 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 144 ;32.357 ;22.500 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 589 ;17.139 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;13.881 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 436 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3518 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 617 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7D7U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1300018907. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-DEC-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29976 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 31.310 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.75800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3LUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M IMIDAZOLE PH8.0, 0.2M NACL, 0.46M REMARK 280 NAH2PO4, 1.84M K2HPO4, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 573 REMARK 465 VAL A 574 REMARK 465 ASN A 575 REMARK 465 ASN A 576 REMARK 465 ILE A 577 REMARK 465 LEU A 578 REMARK 465 GLY B 573 REMARK 465 VAL B 574 REMARK 465 ASN B 575 REMARK 465 ASN B 576 REMARK 465 ILE B 577 REMARK 465 LEU B 578 REMARK 465 ASN C 575 REMARK 465 ASN C 576 REMARK 465 ILE C 577 REMARK 465 LEU C 578 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 708 O HOH B 748 1.96 REMARK 500 O3P 8BR A 601 O HOH A 701 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 721 O HOH C 724 1655 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 539 -57.10 -127.24 REMARK 500 CYS C 492 86.36 -161.62 REMARK 500 ASP C 537 -73.96 -79.11 REMARK 500 VAL C 539 -40.50 -139.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE B 485 GLN B 486 -145.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8BR A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8BR B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8BR C 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7C6B RELATED DB: PDB REMARK 900 PDB ENTRIES FOR THE SAME CITATION DBREF 7D7U A 440 578 UNP Q9UKV8 AGO2_HUMAN 440 578 DBREF 7D7U B 440 578 UNP Q9UKV8 AGO2_HUMAN 440 578 DBREF 7D7U C 440 578 UNP Q9UKV8 AGO2_HUMAN 440 578 SEQRES 1 A 139 LYS GLN PHE HIS THR GLY ILE GLU ILE LYS VAL TRP ALA SEQRES 2 A 139 ILE ALA CYS PHE ALA PRO GLN ARG GLN CYS THR GLU VAL SEQRES 3 A 139 HIS LEU LYS SER PHE THR GLU GLN LEU ARG LYS ILE SER SEQRES 4 A 139 ARG ASP ALA GLY MET PRO ILE GLN GLY GLN PRO CYS PHE SEQRES 5 A 139 CYS LYS TYR ALA GLN GLY ALA ASP SER VAL GLU PRO MET SEQRES 6 A 139 PHE ARG HIS LEU LYS ASN THR TYR ALA GLY LEU GLN LEU SEQRES 7 A 139 VAL VAL VAL ILE LEU PRO GLY LYS THR PRO VAL TYR ALA SEQRES 8 A 139 GLU VAL LYS ARG VAL GLY ASP THR VAL LEU GLY MET ALA SEQRES 9 A 139 THR GLN CYS VAL GLN MET LYS ASN VAL GLN ARG THR THR SEQRES 10 A 139 PRO GLN THR LEU SER ASN LEU CYS LEU LYS ILE ASN VAL SEQRES 11 A 139 LYS LEU GLY GLY VAL ASN ASN ILE LEU SEQRES 1 B 139 LYS GLN PHE HIS THR GLY ILE GLU ILE LYS VAL TRP ALA SEQRES 2 B 139 ILE ALA CYS PHE ALA PRO GLN ARG GLN CYS THR GLU VAL SEQRES 3 B 139 HIS LEU LYS SER PHE THR GLU GLN LEU ARG LYS ILE SER SEQRES 4 B 139 ARG ASP ALA GLY MET PRO ILE GLN GLY GLN PRO CYS PHE SEQRES 5 B 139 CYS LYS TYR ALA GLN GLY ALA ASP SER VAL GLU PRO MET SEQRES 6 B 139 PHE ARG HIS LEU LYS ASN THR TYR ALA GLY LEU GLN LEU SEQRES 7 B 139 VAL VAL VAL ILE LEU PRO GLY LYS THR PRO VAL TYR ALA SEQRES 8 B 139 GLU VAL LYS ARG VAL GLY ASP THR VAL LEU GLY MET ALA SEQRES 9 B 139 THR GLN CYS VAL GLN MET LYS ASN VAL GLN ARG THR THR SEQRES 10 B 139 PRO GLN THR LEU SER ASN LEU CYS LEU LYS ILE ASN VAL SEQRES 11 B 139 LYS LEU GLY GLY VAL ASN ASN ILE LEU SEQRES 1 C 139 LYS GLN PHE HIS THR GLY ILE GLU ILE LYS VAL TRP ALA SEQRES 2 C 139 ILE ALA CYS PHE ALA PRO GLN ARG GLN CYS THR GLU VAL SEQRES 3 C 139 HIS LEU LYS SER PHE THR GLU GLN LEU ARG LYS ILE SER SEQRES 4 C 139 ARG ASP ALA GLY MET PRO ILE GLN GLY GLN PRO CYS PHE SEQRES 5 C 139 CYS LYS TYR ALA GLN GLY ALA ASP SER VAL GLU PRO MET SEQRES 6 C 139 PHE ARG HIS LEU LYS ASN THR TYR ALA GLY LEU GLN LEU SEQRES 7 C 139 VAL VAL VAL ILE LEU PRO GLY LYS THR PRO VAL TYR ALA SEQRES 8 C 139 GLU VAL LYS ARG VAL GLY ASP THR VAL LEU GLY MET ALA SEQRES 9 C 139 THR GLN CYS VAL GLN MET LYS ASN VAL GLN ARG THR THR SEQRES 10 C 139 PRO GLN THR LEU SER ASN LEU CYS LEU LYS ILE ASN VAL SEQRES 11 C 139 LYS LEU GLY GLY VAL ASN ASN ILE LEU HET 8BR A 601 24 HET 8BR B 601 24 HET 8BR C 601 24 HETNAM 8BR 8-BROMO-ADENOSINE-5'-MONOPHOSPHATE FORMUL 4 8BR 3(C10 H13 BR N5 O7 P) FORMUL 7 HOH *210(H2 O) HELIX 1 AA1 THR A 463 ALA A 481 1 19 HELIX 2 AA2 GLY A 497 ASP A 499 5 3 HELIX 3 AA3 SER A 500 TYR A 512 1 13 HELIX 4 AA4 PRO A 527 VAL A 539 1 13 HELIX 5 AA5 MET A 549 ARG A 554 1 6 HELIX 6 AA6 THR A 556 GLY A 572 1 17 HELIX 7 AA7 THR B 463 ALA B 481 1 19 HELIX 8 AA8 GLY B 497 ASP B 499 5 3 HELIX 9 AA9 SER B 500 TYR B 512 1 13 HELIX 10 AB1 PRO B 527 THR B 538 1 12 HELIX 11 AB2 MET B 549 ARG B 554 1 6 HELIX 12 AB3 THR B 556 GLY B 572 1 17 HELIX 13 AB4 THR C 463 ALA C 481 1 19 HELIX 14 AB5 GLY C 497 ASP C 499 5 3 HELIX 15 AB6 SER C 500 TYR C 512 1 13 HELIX 16 AB7 PRO C 527 THR C 538 1 12 HELIX 17 AB8 MET C 549 ARG C 554 1 6 HELIX 18 AB9 THR C 556 GLY C 572 1 17 SHEET 1 AA1 4 PHE A 491 TYR A 494 0 SHEET 2 AA1 4 TRP A 451 CYS A 455 1 N CYS A 455 O LYS A 493 SHEET 3 AA1 4 LEU A 517 LEU A 522 1 O VAL A 519 N ALA A 452 SHEET 4 AA1 4 THR A 544 GLN A 548 1 O GLN A 545 N VAL A 518 SHEET 1 AA2 4 CYS B 492 TYR B 494 0 SHEET 2 AA2 4 TRP B 451 CYS B 455 1 N CYS B 455 O LYS B 493 SHEET 3 AA2 4 LEU B 517 LEU B 522 1 O VAL B 519 N ALA B 452 SHEET 4 AA2 4 THR B 544 GLN B 548 1 O GLN B 545 N VAL B 520 SHEET 1 AA3 4 PHE C 491 TYR C 494 0 SHEET 2 AA3 4 TRP C 451 CYS C 455 1 N ILE C 453 O PHE C 491 SHEET 3 AA3 4 LEU C 517 LEU C 522 1 O VAL C 519 N ALA C 452 SHEET 4 AA3 4 THR C 544 GLN C 548 1 O GLN C 545 N VAL C 520 SITE 1 AC1 16 LEU A 522 GLY A 524 LYS A 525 THR A 526 SITE 2 AC1 16 TYR A 529 LYS A 533 THR A 544 GLN A 545 SITE 3 AC1 16 CYS A 546 GLN A 548 LYS A 570 HOH A 701 SITE 4 AC1 16 HOH A 725 HOH A 735 HOH A 749 HOH A 770 SITE 1 AC2 18 LEU B 522 GLY B 524 LYS B 525 THR B 526 SITE 2 AC2 18 TYR B 529 LYS B 533 THR B 544 GLN B 545 SITE 3 AC2 18 CYS B 546 GLN B 548 LYS B 570 HOH B 704 SITE 4 AC2 18 HOH B 716 HOH B 720 HOH B 729 HOH B 735 SITE 5 AC2 18 HOH B 744 HOH B 749 SITE 1 AC3 12 LEU C 522 GLY C 524 LYS C 525 THR C 526 SITE 2 AC3 12 TYR C 529 LYS C 533 THR C 544 GLN C 545 SITE 3 AC3 12 CYS C 546 GLN C 548 LYS C 570 HOH C 714 CRYST1 47.170 65.770 40.790 105.83 96.46 87.56 P 1 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021200 -0.000903 0.002240 0.00000 SCALE2 0.000000 0.015218 0.004267 0.00000 SCALE3 0.000000 0.000000 0.025624 0.00000